These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24164016)

  • 1. [Opiate substitution programs: last chance programs or deal for quality of life?].
    Manghi R; Soulignac R; Zullino D
    Rev Med Suisse; 2013 Sep; 9(398):1669-71. PubMed ID: 24164016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health promotion and prevention strategies.
    Bradbury-Golas K
    Nurs Clin North Am; 2013 Sep; 48(3):469-83, vii. PubMed ID: 23998773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia.
    Horyniak D; Dietze P; Larance B; Winstock A; Degenhardt L
    Int J Drug Policy; 2011 Mar; 22(2):167-71. PubMed ID: 21112758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining structural violence in opioid pharmacotherapy treatment in Australia: sweating the "small stuff" in a liberal paradise.
    Treloar C; Valentine K
    Int J Drug Policy; 2013 Nov; 24(6):e11-3. PubMed ID: 23711673
    [No Abstract]   [Full Text] [Related]  

  • 5. Personality differences between drug injectors and non-injectors among substance-dependent patients in substitution treatment.
    Saint-Lèbes J; Rodgers R; Birmes P; Schmitt L
    Am J Drug Alcohol Abuse; 2012 Mar; 38(2):135-9. PubMed ID: 22220585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-prescribed use of substitution medication among German drug users--prevalence, motives and availability.
    Schmidt CS; Schulte B; Wickert C; Thane K; Kuhn S; Verthein U; Reimer J
    Int J Drug Policy; 2013 Nov; 24(6):e111-4. PubMed ID: 23726899
    [No Abstract]   [Full Text] [Related]  

  • 7. The politics of providing opioid pharmacotherapy.
    Radcliffe P; Parkes T
    Int J Drug Policy; 2013 Nov; 24(6):e6-10. PubMed ID: 24183331
    [No Abstract]   [Full Text] [Related]  

  • 8. The rights of drug treatment patients: Experience of addiction treatment in Poland from a human rights perspective.
    Klingemann J
    Int J Drug Policy; 2017 May; 43():67-73. PubMed ID: 28231439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caught between the "soft" and "hard" arms of the state: a conceptual apparatus for situating the formative role of drug user organizations in national policy-making and local service delivery--a commentary.
    Zibbell JE
    Subst Use Misuse; 2012 Apr; 47(5):558-65. PubMed ID: 22428824
    [No Abstract]   [Full Text] [Related]  

  • 10. Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs.
    Millson P; Challacombe L; Villeneuve PJ; Strike CJ; Fischer B; Myers T; Shore R; Hopkins S
    Eur Addict Res; 2006; 12(2):74-82. PubMed ID: 16543742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid pharmacotherapy: Treatment, regimes, constructions and control.
    Neale J
    Int J Drug Policy; 2013 Nov; 24(6):e1-5. PubMed ID: 24075399
    [No Abstract]   [Full Text] [Related]  

  • 12. Dealing with aggressive methadone patients in community pharmacy: a critical incident study.
    Irwin A; Laing C; Mearns K
    Res Social Adm Pharm; 2012; 8(6):542-51. PubMed ID: 22381914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scale-up of opioid substitution therapy in India: opportunities and challenges.
    Kumar MS; Agrawal A
    Int J Drug Policy; 2012 Mar; 23(2):169-70. PubMed ID: 22280919
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug consumption facility as part of a primary health care centre for problem drug users - which clients are attracted?
    Scherbaum N; Specka M; Bombeck J; Marrziniak B
    Int J Drug Policy; 2009 Sep; 20(5):447-9. PubMed ID: 19269803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contingency management in opioid substitution treatment].
    Specka M; Böning A; Scherbaum N
    Fortschr Neurol Psychiatr; 2011 Jul; 79(7):395-403. PubMed ID: 21108163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In control?: Ukrainian opiate substitution treatment patients strive for a voice in their treatment.
    Golovanevskaya M; Vlasenko L; Saucier R
    Subst Use Misuse; 2012 Apr; 47(5):511-21. PubMed ID: 22428819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing access to opioid maintenance treatment: the role of primary care in France.
    Roux P; Lions C; Carrieri MP
    Int J Drug Policy; 2015 Apr; 26(4):434-5. PubMed ID: 25683137
    [No Abstract]   [Full Text] [Related]  

  • 18. An experimental study of aggressive and neutral interpretative bias in opiate-dependent and opiate-abstinent men.
    Clair J; Martin L; Bond AJ; O'Ryan D; Davis P; Curran HV
    J Psychopharmacol; 2009 Jun; 23(4):428-35. PubMed ID: 18562417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semantic priming and verbal learning in current opiate users, ex-users and non-user controls.
    Battistella S; Constantinou N; Morgan CJ; Davis P; O'Ryan D; Curran HV
    Hum Psychopharmacol; 2012 Sep; 27(5):499-506. PubMed ID: 22996617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.